Project Aims to Scale-Up Commercial Platform for DNA Marking of Bearings

STONY BROOK, N.Y. August 10, 2017 Applied DNA Sciences, Inc. (“Applied DNA,” “the company,” NASDAQ: APDN), is commencing production-scale DNA marking of bearings with a global leader in the manufacture of bearings, at a domestic manufacturing facility.  The work will be performed under the newly awarded Rapid Innovation Fund (RIF) contract issued by the Office of the Secretary of Defense (OSD) on behalf of the Defense Logistics Agency (DLA), and reflects Applied DNA’s efforts to commercialize processes and methodologies developed for the Department of Defense and apply them to commercial OEMs.

This production-scale project is a follow-up to successful pilot conducted under Applied DNA’s prior OSD RIF contract, completed in August of 2016.  Through collaborative efforts led by the R&D team of the US-based bearing manufacturer, along with DLA Aviation’s subject matter experts from Richmond, VA, Applied DNA scientists tested and qualified blending SigNature® DNA into preservative lubricants used in the manufacturing of bearings. This innovative solution for DNA marking of bearings should provide little to no impact on the manufacturing process, which will be confirmed in the initial phase of production testing.

The immediate goal of the project is to assist in securing the Department of Defense supply chain, but Applied DNA believes the platform can easily be leveraged by commercial stakeholders, globally. Preservative lubricants are used in wide-ranging industrial applications, tool manufacturing, pneumatic equipment and small arms.

Bob MacDowell, Applied DNA Director, Government and Military Program Sales commented, “Our DNA-based solutions provide significant value in many different applications, allowing traceability to source along a supply chain. The most effective deployment of the DNA is at the point of manufacture, which creates the broadest platform possible and enables all stakeholders to benefit from the solution.”

“Agriculture, industrial equipment and the automotive industry are all focus markets for the bearings industry at large, which align well with Applied DNA’s roadmap for current markets to penetrate.  We are hopeful the success of this production project, will secure DLA’s bearing supply chain, and lead to larger opportunities in additional markets where both the bearing manufacturer and their customers can mutually benefit,” stated Dr. James Hayward, president and CEO of Applied DNA.

The aerospace bearings market was valued at $7.88 billion in 2016 and is projected to reach $11.19 billion by 20221.  The overall global market for bearings, currently valued at greater than $84 billion, is projected to grow by 67 percent to $140 billion by 20222.


About Applied DNA Sciences

Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics.

We make life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-based “CertainT™” platform can be used to identify, tag, test, and track products, to help assure authenticity, origin, traceability, sustainability and quality of products.

SigNature® DNA describes the core technology ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature® T and fiberTyping®, targeted toward textiles and apparel, BackTrac™ and DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track-and-trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.

Visit for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

The Company’s common stock is listed on NASDAQ under the symbol APDN, and its warrants are listed under the symbol APDNW.

Forward Looking Statements
The statements made by APDN in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 6, 2016, and our subsequent quarterly reports on Form 10-Q filed on February 9, 2017, and May 11, 2017 which are available at APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

Investor contact: Sanjay Hurry, LHA Investor Relations,  212-838-3777,
Media: Susan Forman, Dian Griesel Int’l, 212-825-3210,
Program Contact: Bob MacDowell, 631-240-8823,
twitter: @APDN